Profile of pharmaceutical interventions of a pharmacotherapeutic follow-up model for diabetic patients in a community pharmacy
DOI:
https://doi.org/10.1590/s2175-97902022e20956Keywords:
Primary Health Care (PHC), Community Pharmacy, Type 2 Diabetes Mellitus (T2DM), Pharmacoepidemiology, Pharmaceutical CareAbstract
The insertion of Pharmaceutical Care in Primary Health Care (PHC) improves patients’ clinical outcomes and quality of life. Pharmacotherapeutic follow-up can contribute to the management of chronic diseases such as diabetes, promoting better glycemic control and adherence to therapy. This study aimed to assess the Drug-therapy Problems (DTPs) and Pharmacist Interventions (PIs) on the pharmacotherapeutic management in patients with type 2 diabetes mellitus (T2DM) in a community pharmacy. A quantitative, retrospective, and cross-sectional study was conducted in a Pharmaceutical Care Program within the PHC in Juiz de Fora (Minas Gerais, Brazil). Inclusion criteria were patients with T2DM above 18, who attended at least three pharmaceutical consultations between July 2016 and October 2018 and presented two or more glycated hemoglobin tests. The study group (n = 17) was largely composed of women (65%), elderly (76%), sedentary (72%), and obese people (52%). The resolution was achieved in 79% of the DTPs identified (n = 115). Most of DTPs were related to administration and adherence to pharmacotherapy (46%). 60% of the 437 PIs involved the provision of information and counseling. In other words, accessible interventions lead to high resolvability. Therefore, clinical actuation of pharmacists could improve the prognosis in diabetes treatment.
Downloads
References
Aguirre NG, Martínez AC, Muñoz L, Avellana MC, Marco JV, Diez-Manglano J. Polypathology, polypharmacy, medication regimen complexity and drug therapy appropriateness. Rev Clin Esp. 2017;217(5):289-95.
Alvares J, Alves MCGP, Escuder MML, Almeida AM, Izidoro JB, Junior AAG, et al. National Survey on Access, Use and Promotion of Rational Use of Medicines: methods. Rev Saude Publica. 2017;51(suppl 2):4s.
Aquino JA, Baldoni AO, Oliveira CDL, Cardoso CS, Figueiredo RC, Sanches C. Pharmacotherapeutic empowerment and its effectiveness control in patients with Diabetes Mellitus. Diabetes Metab Syndr. 2019;13(1):137-42.
Araújo SQ, Costa KS, Luiza VL, Lavras C, Santana EA, Tavares NUL. The organization of pharmaceutical services by ‘health region’ in Brazil’s Unified Health System. Ciên Saude Colet. 2017;22(4):1181-91.
Ascef BO, Haddad JPA, Álvares J, Júnior AAG, Costa EA, Acurcio FA, et al. Health-related quality of life of patients of Brazilian primary health care. Rev Saude Publica . 2017;51(suppl 2):22s.
Borges DB, Lacerda JT. Actions aimed at the Diabetes Mellitus control in Primary Health Care: a proposal of evaluative model. Saude Debate. 2018;42(116):162-178.
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Assistência Farmacêutica e Insumos Estratégicos. Cuidado farmacêutico na atenção básica, caderno 1: Serviços farmacêuticos na atenção básica à saúde. Brasília: Ministério da Saúde; 2014. 106 p.
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Assistência Farmacêutica e Insumos Estratégicos. Cuidado farmacêutico na atenção básica, caderno 4: Resultados do projeto de implantação do cuidado farmacêutico no Município de Curitiba. Brasília: Ministério da Saúde ; 2015. 100 p.
Cazarim MS, Freitas O, Penaforte TR, Achcar A, Pereira LRL. Impact assessment of pharmaceutical care in the management of hypertension and coronary risk factors after discharge. PloS One. 2016;11(6):1-14.
Conceição RA, Silva PN, Barbosa MLC. Drugs for the treatment of type II diabetes: a visit to the past and a look to the future. Rev Virtual Quim. 2017;9(2):514-34.
Conselho Federal de Farmácia. CFF. Serviços farmacêuticos diretamente destinados ao paciente, à família e à comunidade: contextualização e arcabouço conceitual. Brasília: Conselho Federal de Farmácia; 2016. 200 p.
Correr CJ, Noblat LACB, Castro MS. Modelos de Seguimento Farmacoterapêutico. In: Soares L, editor. Assistência Farmacêutica no Brasil: Política, Gestão e Clínica, volume 5: Atuação Clínica do Farmacêutico. Florianópolis: UFSC Publisher; 2016. p. 221-51.
Costa EA, Araújo PS, Penaforte TR, Barreto JL, Junior AG, Acurcio FA, et al. Conceptions on pharmaceutical services in Brazilian primary health care. Rev Saude Publica . 2017;51(suppl 2):5s.
Costa JP, Jorge MSB, Vasconcelos MGF, Paula ML, Bezerra IC. Solvability of the caretaking in primary care: multiprofessional articulation and services network. Saude Debate . 2014;38(103):733-743.
Cunha GH, Barbosa RVA, Fontenele MSM, Lima MAC, Franco LB, Fechine FC. Insulin therapy waste produced in the households of people with diabetes monitored in Primary Care. Rev Bras Enferm. 2017;70(3):618-25.
Hernandez DS, Castro MMS, Dáder MJF. Método Dáder. Guía de seguimiento Farmacoterapéutico. Tercera edición. Granada: Universidad de Granada; 2007. 128 p.
Huszcz RS, Sato MDO, Santiago RM. Pharmaceutical surgery: the pharmacist’s role in the SUS. Revista Saúde Desenvolvimento. 2018;12(10):144-59.
International Diabetes Federation. IDF. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: IDF, 2019. Available at: https://diabetesatlas.org/en/resources/
» https://diabetesatlas.org/en/resources/
Lade CG, Marins JCB, Lims LM, Reis JS, Reis HHT, Caetano IT, et al. Analysis of health indicators in patients with diabetes treated at Hiperdia Center of Viçosa. Mundo Saude. 2016;40(3):283-92.
Malta DC, Bernal RTI, Neto EV, Curci KA, Pasinato MTM, Lisbôa RM, et al. Noncommunicable diseases, risk factors, and protective factors in adults with and without health insurance. Ciên Saude Colet . 2020;25(8):2973-83.
Nascimento RCR, Álvares J, Júnior AAG, Gomes IC, Costa EA, Leite SN, et al. Availability of essential medicines in primary health care of the Brazilian Unified Health System. Rev Saude Publica . 2017;51(suppl 2):10s.
Nicoletti MA, Kubota LK. Benefits from practices of pharmaceutical care in hypertension and type 2 diabetes to be conducted in health units. Infarma. 2017;29(4):307-12.
Provin MP, De Paula-Campos A, De Oliveira NSE, Amaral RG. Pharmaceutical Care in Goiânia: inclusion of the pharmacist in the Family Health Strategy. Saúde Soc. 2010;19(3):717-24.
Ramos LB, Tavares NUL, Bertoldi AD, Farias MR, Oliveira MA, Luiza VL, et al. Polypharmacy and polymorbidity in older adults in Brazil: a public health challenge. Rev Saude Publica . 2016;50(suppl 2):9s.
Ruppar TM, Conn VS. Medication adherence: still looking for the answer. Res Gerontol Nurs. 2011;4(3):159-60.
Santos FTC, Silva DL, Tavares NUL. Pharmaceutical clinical services in basic care in a region of the municipality of São Paulo. Braz J Pharm Sci. 2018;54(3):1-11.
Silva AB, Engroff P, Sgnaolin V, Ely LS, Gomes I. Prevalence of diabetes mellitus and medication adherence in elderly of the Family Health Program in Porto Alegre. Cad Saude Colet. 2016;24(3):308-16.
Sociedade Brasileira de Diabetes. SBD. Diretrizes da Sociedade Brasileira de Diabetes 2019-2020. São Paulo: Clannad. 2019. 489 p.
Tavares NUL, Bertoldi AD, Mengue SS, Arrais PSD, Luiza VL, Oliveira MA, et al. Factors associated with low adherence to medicine treatment for chronic diseases in Brazil. Rev Saude Publica . 2016;50(suppl 2):10s.
World Health Organization. WHO. Quality Assurance and Safety of Medicines Team. The safety of medicines in public health programmes: pharmacovigilance an essential tool. Geneva, Switzerland: WHO Press; 2006. 60 p.
World Health Organization. WHO. World report on ageing and health. Geneva, Switzerland: WHO Press ; 2015. 246 p.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
